chronic atrophic gastritis with intestinal metaplasia
Conditions
Interventions
treatment group: Piwei Peiyuan Prescription
control group:folic acid tablet
Sponsors
Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Age: 18-70 years old, no gender limitation; (2) It conforms to the diagnostic criteria of chronic atrophic gastritis with intestinal metaplasia and TCM syndrome of spleen and stomach weakness; (3) Hp negative patients or previous Hp infection, successful eradication treatment for more than six months and no symptomatic infection; (4) Those who voluntarily participate in the clinical trial and give informed consent and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) complicated with peptic ulcer, pathologically confirmed as high-grade intraepithelial neoplasia or suspected malignant transformation; (2) have a history of severe digestive diseases or abdominal surgery; (3) pregnant and lactating women; (4) serious diseases associated with the study evaluation, such as severe blood diseases, liver disease, heart disease, kidney disease, malignant tumor, etc.; (5) patients with disabilities as prescribed by law; (6) Long-term use of NSAIDS and history of alcoholism; (7) allergic to drugs used in this study; (8) Participants in clinical trials of other drugs in the last 4 weeks; Or have used mofuchun, morodane, folic acid and other preparations in recent 2 weeks; (9) Easy to cause lost visitors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pathological diagnosis;The pathological integral; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome Integral;Results of gastroscopy;life quality score;serological indicator;Anxiety indicators; | — |
Countries
China
Contacts
Public ContactLi Xuejun
Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Outcome results
None listed